Kortykosteroidowe

⚕ Symptoma ist primär ein Nachschlagewerk zur Benutzung durch medizinisches Fachpersonal. Mit dem Benutzen dieser Webseite akzeptieren Sie, dass die Webseite nicht als System zur diagnostischen Entscheidungsfindung benutzt werden darf. Keinesfalls darf diese Webseite benutzt werden, um eine Diagnose zu erstellen oder um Diagnosen von medizinischem Fachpersonal zu ersetzen. Die Entscheidung über eine Diagnose obliegt immer dem Arzt. Die angebotenen Informationen dürfen auf keinen Fall als Ersatz ärztlichen Rates angesehen werden! Diese Internetseite kann und darf NICHT benutzt werden, um eigenständig Diagnosen zu stellen oder Behandlungen zu beginnen. Bei Beschwerden oder Fragen jeglicher medizinischer Art konsultieren Sie direkt Ihren Arzt oder Apotheker.

In 1952, . Peterson and . Murray of Upjohn developed a process that used Rhizopus mold to oxidize progesterone into a compound that was readily converted to cortisone. [46] The ability to cheaply synthesize large quantities of cortisone from the diosgenin in yams resulted in a rapid drop in price to US $6 per gram, falling to $ per gram by 1980. Percy Julian's research also aided progress in the field. [47] The exact nature of cortisone's anti-inflammatory action remained a mystery for years after, however, until the leukocyte adhesion cascade and the role of phospholipase A2 in the production of prostaglandins and leukotrienes was fully understood in the early 1980s.

To assess the efficacy and tolerability of steroids in epileptic syndromes with continuous spike-waves during slow-wave sleep (CSWS), charts of 44 children (25 boys) who received corticosteroids for cognitive and/or behavioral deterioration associated with CSWS were retrospectively reviewed. Awake and sleep electroencephalography (EEG) records, clinical and neuropsychological assessments were available before, during, and after corticosteroid therapy. Evaluation focused on effects on EEG, behavior, and cognition. All but two patients received hydrocortisone (initial dose of 5 mg/kg/day). The treatment was slowly tapered with a total duration of 21 months. There were 18 symptomatic and 26 cryptogenic cases. Mean age was 7 years and mean intelligence quotient/developmental quotient (IQ/DQ) was 65. Mean CSWS duration before corticosteroid treatment was years. Twenty patients had tried more than two antiepileptic drugs (AEDs) before steroids. Positive response to steroids was found during the first 3 months of treatment in 34 of 44 patients (%), with normalization of the EEG in 21 patients. Relapse occurred in 14 of them. Hence, 20 patients (%) were long-term responders after a single but prolonged trial of steroids, including all four cases of Landau-Kleffner syndrome. Positive response to steroids was highly significantly associated with higher IQ/DQ. Shorter CSWS duration, but not age, etiology, or previous AED trials, was associated with positive response to steroids. Early discontinuation of the treatment for side effects was encountered in seven patients. We conclude that corticosteroids are safe and efficient for treatment of epilepsy with CSWS. Poor responders are patients with very low IQ and long duration of CSWS.

Kortykosteroidowe

kortykosteroidowe

Media:

kortykosteroidowekortykosteroidowekortykosteroidowekortykosteroidowekortykosteroidowe

http://buy-steroids.org